Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Mett

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Journal of Medicinal Chemistry|January 8, 1993
S-adenosylmethionine decarboxylase inhibitors: new aryl and heteroaryl analogues of methylglyoxal bis(guanylhydrazone)J Stanek, G Caravatti, H G Capraro, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 1995
Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine classE Buchdunger, J Zimmermann, H Mett, et al.
Archiv Der Pharmazie|July 1, 1996
Phenylamino-pyrimidine (PAP) derivatives: a new class of potent and selective inhibitors of protein kinase C (PKC)J Zimmermann, G Caravatti, H Mett, et al.
The Journal of Antibiotics|November 1, 1995
Protein tyrosine kinase and protein kinase C inhibition by fungal anthraquinones related to emodinA Fredenhagen, H Mett, T Meyer, et al.
Cancer Research|January 1, 1996
Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivativeE Buchdunger, J Zimmermann, H Mett, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2000
Substituted 5,7-diphenyl-pyrrolo[2,3d]pyrimidines: potent inhibitors of the tyrosine kinase c-SrcM Missbach, E Altmann, L Widler, et al.
The Journal of Antibiotics|March 1, 1995
Paeciloquinones A, B, C, D, E and F: new potent inhibitors of protein tyrosine kinases produced by Paecilomyces carneus. I. Taxonomy, fermentation, isolation and biological activityF Petersen, A Fredenhagen, H Mett, et al.
Journal of Clinical Pharmacology|February 1, 1988
Penems: in vitro and in vivo experimentsO Zak, M Lang, R Cozens, et al.
Pharmacology & Therapeutics|August 24, 1999
Inhibitors of protein kinases: CGP 41251, a protein kinase inhibitor with potential as an anticancer agentD Fabbro, E Buchdunger, J Wood, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Pharmacological properties of the ornithine decarboxylase inhibitor 3-aminooxy-1-propanamine and several structural analoguesH Mett, J Stanek, J A Lopez-Ballester, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Journal of Medicinal Chemistry|January 8, 1993
S-adenosylmethionine decarboxylase inhibitors: new aryl and heteroaryl analogues of methylglyoxal bis(guanylhydrazone)J Stanek, G Caravatti, H G Capraro, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 1995
Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine classE Buchdunger, J Zimmermann, H Mett, et al.
Archiv Der Pharmazie|July 1, 1996
Phenylamino-pyrimidine (PAP) derivatives: a new class of potent and selective inhibitors of protein kinase C (PKC)J Zimmermann, G Caravatti, H Mett, et al.
The Journal of Antibiotics|November 1, 1995
Protein tyrosine kinase and protein kinase C inhibition by fungal anthraquinones related to emodinA Fredenhagen, H Mett, T Meyer, et al.
Cancer Research|January 1, 1996
Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivativeE Buchdunger, J Zimmermann, H Mett, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2000
Substituted 5,7-diphenyl-pyrrolo[2,3d]pyrimidines: potent inhibitors of the tyrosine kinase c-SrcM Missbach, E Altmann, L Widler, et al.
The Journal of Antibiotics|March 1, 1995
Paeciloquinones A, B, C, D, E and F: new potent inhibitors of protein tyrosine kinases produced by Paecilomyces carneus. I. Taxonomy, fermentation, isolation and biological activityF Petersen, A Fredenhagen, H Mett, et al.
Journal of Clinical Pharmacology|February 1, 1988
Penems: in vitro and in vivo experimentsO Zak, M Lang, R Cozens, et al.
Pharmacology & Therapeutics|August 24, 1999
Inhibitors of protein kinases: CGP 41251, a protein kinase inhibitor with potential as an anticancer agentD Fabbro, E Buchdunger, J Wood, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Pharmacological properties of the ornithine decarboxylase inhibitor 3-aminooxy-1-propanamine and several structural analoguesH Mett, J Stanek, J A Lopez-Ballester, et al.
Pageof 6